Undiagnosed Sleep-Disordered Breathing Worsens Heart Function in HCM Patients: JAMA
Written By : Medha Baranwal
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2025-09-16 02:45 GMT | Update On 2025-09-16 04:03 GMT
Advertisement
UK: Researchers have found in a new study that sleep-disordered breathing (SDB) is highly prevalent in hypertrophic cardiomyopathy (HCM) patients and is linked to adverse myocardial remodeling, greater diastolic dysfunction, and elevated troponin-T levels, indicating subclinical myocardial injury. The findings support further trials on treating SDB to improve outcomes in HCM.
The study, published in
A total of 154 adults with HCM, identified from an institutional registry between 2018 and 2024, underwent overnight polysomnography, the gold standard for diagnosing sleep-disordered breathing. Participants with a prior diagnosis of SDB or pregnancy were excluded. Researchers assessed echocardiographic measures, biomarker levels, and functional status, with data analysis conducted independently of sleep study results.
The study led to the following findings:
- Sleep-disordered breathing (SDB) was identified in nearly 60% of patients, with most cases previously undiagnosed.
- Patients with SDB showed higher left ventricular mass, greater diastolic dysfunction, and elevated baseline troponin-T levels, along with larger overnight rises in troponin, pointing to subclinical myocardial injury.
- Over half of the HCM patients with SDB reported New York Heart Association class II or III symptoms, compared with only one-fourth of those without SDB.
- Hypertension and diabetes were more common in patients with SDB, while rates of atrial fibrillation and prior myectomy were comparable between groups.
The authors highlighted that SDB may play a key role in worsening the structural and functional abnormalities seen in HCM, adding to the overall disease burden. As SDB is often silent and under-recognized, its presence in this population may go unnoticed without systematic evaluation.
The researchers noted certain limitations, including the single-center design, predominantly European cohort, and reliance on routine echocardiograms, which may have introduced variability. Classifying all hypopneas as obstructive could also have underestimated the true burden of central sleep apnea.
The study highlights the importance of considering SDB as a comorbidity in patients with HCM, particularly in those with unexplained worsening of symptoms or evidence of diastolic dysfunction. The authors stressed the need for randomized clinical trials to determine whether treating SDB can improve remodeling, arrhythmic risk, and long-term outcomes in this patient population.
Reference:
Karim S, Chahal A, Venkataraman S, et al. Prevalence and Clinical Implications of Sleep Apnea in Hypertrophic Cardiomyopathy. JAMA Cardiol. Published online September 03, 2025. doi:10.1001/jamacardio.2025.2877
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.